NASDAQ:TKNO Alpha Teknova (TKNO) Stock Price, News & Analysis $6.49 -0.16 (-2.41%) Closing price 04/25/2025 04:00 PM EasternExtended Trading$6.51 +0.02 (+0.31%) As of 04/25/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Alpha Teknova Stock (NASDAQ:TKNO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Alpha Teknova alerts:Sign Up Key Stats Today's Range$6.31▼$6.5750-Day Range$4.51▼$7.9952-Week Range$1.16▼$10.37Volume199,097 shsAverage Volume359,081 shsMarket Capitalization$346.81 millionP/E RatioN/ADividend YieldN/APrice Target$8.50Consensus RatingBuy Company OverviewAlpha Teknova, Inc. produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.Read More… Alpha Teknova Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks38th Percentile Overall ScoreTKNO MarketRank™: Alpha Teknova scored higher than 38% of companies evaluated by MarketBeat, and ranked 730th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingAlpha Teknova has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageAlpha Teknova has only been the subject of 1 research reports in the past 90 days.Read more about Alpha Teknova's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Alpha Teknova are expected to grow in the coming year, from ($0.58) to ($0.36) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Alpha Teknova is -8.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Alpha Teknova is -8.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAlpha Teknova has a P/B Ratio of 2.94. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Alpha Teknova's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted26.65% of the float of Alpha Teknova has been sold short.Short Interest Ratio / Days to CoverAlpha Teknova has a short interest ratio ("days to cover") of 6.5.Change versus previous monthShort interest in Alpha Teknova has recently increased by 11.86%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAlpha Teknova does not currently pay a dividend.Dividend GrowthAlpha Teknova does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted26.65% of the float of Alpha Teknova has been sold short.Short Interest Ratio / Days to CoverAlpha Teknova has a short interest ratio ("days to cover") of 6.5.Change versus previous monthShort interest in Alpha Teknova has recently increased by 11.86%, indicating that investor sentiment is decreasing significantly. News and Social Media3.0 / 5News Sentiment1.39 News SentimentAlpha Teknova has a news sentiment score of 1.39. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.03 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Alpha Teknova this week, compared to 1 article on an average week. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Alpha Teknova insiders have not sold or bought any company stock.Percentage Held by Insiders15.20% of the stock of Alpha Teknova is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 13.81% of the stock of Alpha Teknova is held by institutions.Read more about Alpha Teknova's insider trading history. Receive TKNO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alpha Teknova and its competitors with MarketBeat's FREE daily newsletter. Email Address TKNO Stock News HeadlinesAlpha Teknova, Inc. to Report First Quarter Financial Results on May 8, 2025April 24 at 8:34 PM | quiverquant.comTeknova to Report First Quarter 2025 Financial Results on May 8, 2025April 24 at 8:04 PM | globenewswire.com$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.April 27, 2025 | Stansberry Research (Ad)Alpha Teknova, Pluristyx launch proprietary PluriFreeze cryopreservation systemMarch 20, 2025 | markets.businessinsider.comTeknova and Pluristyx Launch Proprietary PluriFreeze™ Cryopreservation System to Accelerate the Development of Cell TherapiesMarch 19, 2025 | markets.businessinsider.comTeknova and Pluristyx Launch Proprietary PluriFreeze™ Cryopreservation System to Accelerate the Development of Cell TherapiesMarch 19, 2025 | globenewswire.comTeknova, Pluristyx announce collaboration over next-generation cell therapiesMarch 11, 2025 | markets.businessinsider.comTeknova and Pluristyx Announce Collaboration to Streamline the Manufacture of Next-Generation Cell TherapiesMarch 11, 2025 | globenewswire.comSee More Headlines TKNO Stock Analysis - Frequently Asked Questions How have TKNO shares performed this year? Alpha Teknova's stock was trading at $8.35 at the beginning of 2025. Since then, TKNO shares have decreased by 22.3% and is now trading at $6.49. View the best growth stocks for 2025 here. How were Alpha Teknova's earnings last quarter? Alpha Teknova, Inc. (NASDAQ:TKNO) posted its earnings results on Tuesday, March, 4th. The company reported ($0.11) earnings per share (EPS) for the quarter. The business had revenue of $9.27 million for the quarter, compared to analyst estimates of $9.10 million. Alpha Teknova had a negative net margin of 87.17% and a negative trailing twelve-month return on equity of 35.30%. Read the conference call transcript. When did Alpha Teknova IPO? Alpha Teknova (TKNO) raised $90 million in an initial public offering on Friday, June 25th 2021. The company issued 6,000,000 shares at $14.00-$16.00 per share. Who are Alpha Teknova's major shareholders? Alpha Teknova's top institutional investors include Conestoga Capital Advisors LLC (0.36%) and Bay Colony Advisory Group Inc d b a Bay Colony Advisors (0.02%). Insiders that own company stock include Telegraph Hill Partners Iv, L, Ted Davis, J Matthew Mackowski, Stephen Gunstream, Matthew Lowell, Damon Terrill, Lisa Hood and Ken Gelhaus. View institutional ownership trends. How do I buy shares of Alpha Teknova? Shares of TKNO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Alpha Teknova own? Based on aggregate information from My MarketBeat watchlists, some other companies that Alpha Teknova investors own include Myomo (MYO), Cassava Sciences (SAVA), Heron Therapeutics (HRTX), Taboola.com (TBLA), Ultralife (ULBI), NVIDIA (NVDA) and Sensus Healthcare (SRTS). Company Calendar Last Earnings3/04/2025Today4/27/2025Next Earnings (Estimated)5/12/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Diagnostic substances Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:TKNO CIK1850902 Webwww.teknova.com Phone831-637-1100FaxN/AEmployees240Year FoundedN/APrice Target and Rating Average Stock Price Target$8.50 High Stock Price Target$12.00 Low Stock Price Target$5.00 Potential Upside/Downside+31.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.59) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-36,780,000.00 Net Margins-87.17% Pretax Margin-88.14% Return on Equity-35.30% Return on Assets-24.52% Debt Debt-to-Equity Ratio0.12 Current Ratio4.73 Quick Ratio3.94 Sales & Book Value Annual Sales$37.75 million Price / Sales9.19 Cash FlowN/A Price / Cash FlowN/A Book Value$2.21 per share Price / Book2.94Miscellaneous Outstanding Shares53,437,000Free Float45,205,000Market Cap$346.81 million OptionableNot Optionable Beta0.54 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (NASDAQ:TKNO) was last updated on 4/27/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Teknova, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alpha Teknova With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.